Pune: Emcure Pharmaceuticals Limited has announced the incorporation of a new wholly-owned subsidiary named Emcure Wellness Private Limited. The new entity was officially incorporated on July ...

Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...

Emcure signs exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic brands Amaryl and Cetapin ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Emcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new equity shares valued at ₹800 crore and existing shareholders issuing 1.14 crore equity shares in ...

Emcure Pharmaceuticals Limited announced the appointment of Mr. R.S. Vasan as President - India Business and Senior ...

Emcure also has operations in Canada, having acquired Ottawa-based International Pharmaceutical Generics and its marketing operation Marcan Pharmaceuticals in 2016.

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals, a Pune-based company and a powerhouse in the pharmaceutical industry, has received approval from the market regulator SEBI to launch its much anticipated Initial Public ...

Emcure Pharmaceuticals and Sanofi India have entered into a distribution agreement to promote Sanofi's oral anti-diabetic products, Amaryl and Cetapin, across India.